Notes / Company

Kwality Pharmaceuticals Ltd.

KPL BSE 539997 ISIN INE552U01010 Pharmaceuticals

Fundamentals

Market cap: ₹2,528 cr
P/E: 37.54×
ROE: 15.09%
Debt / equity: 0.43
52-week range: 828.80 — 2600.00

Research on Tijori Finance

Company snapshot

Kwality Pharmaceuticals Ltd.

Pharmaceuticals

₹2,325 cr

P/E 34.53×

Latest quarter · Mar 2026

Sales₹157 cr

Net profit₹25 cr

Op. margin+24.7%

EPS₹24.38

Strength & growth

Debt / equity0.43×

Current ratio1.67×

Sales CAGR+28.9%

The timeline — 1 note on Kwality Pharmaceuticals Ltd.

May 2026

21 May 26 · 6:32 PM IST Brief

Brief · Earnings · Small cap

Kwality Pharma targets ₹850 cr by FY28, bets ₹270 cr on oncology and biosimilars

The company moved its biosimilar focus from Alteplase to Pembrolizumab and set a 30% EBITDA margin target for FY29.

Verify on exchange BSE filings for KPL NSE filings for KPL Tijori Finance company page